Thus, our findings for the first time revealed the immunological role of YOD1 in regulating NLRP3 inflammasome activation and coagulation in MRSA sepsis, and also provided a potential therapeutic target to treat sepsis-induced DIC. Here, NLRP3 is linked to Sepsis.